Research Articles from Managed Care

Andrea DeVries, PhD Gosia Sylwestrzak, MA Abiy Agiro, PhD Thomas Power, MD

UM for outpatient discretionary echocardiography appeared to reduce testing rates significantly

Kathryn S. Kolibaba, MD

Although this practice can optimize long-term patient outcomes, it is not routine in clinical practice

Navin K. Singh, MD Nancy L. Reaven, MA Susan E. Funk, MBA

There was little difference between the options in terms of the frequency and cost of return visits. Patients receiving one-stage reconstructions returned slightly less often for breast-related services during the first 18 months after reconstruction, but the difference was not statistically significant.

Donald W. Bradley, MD Gwen Murphy RD, PhD Linda G. Snetselaar, RD, PhD, LD Esther F. Myers, PhD, RD, FADA Laura G. Qualls, MHA

Overweight or obese patients who participated in a medical nutrition therapy benefit sponsored through their insurer were compared with individuals who did not participate. Outcomes, including weight change, body mass index, waist circumference, and physical exercise, were collected at baseline and 2 years later.

Nicole C. Ferko MSc Natalie Borisova PhD Parisa Airia, PhD Daniel T Grima, MSc Melissa F Thompson, MBA

Using case studies, researchers assess the effect of rebate rates on the cost-effectiveness of two oral bisphosphonates that are competing for tier 2 positioning

Juliana Meyers, MA Sean Candrilli, PhD Richard Allen, PhD Ranjani Manjunath, MPH Michael Calloway, PhD

The researchers find that the costs of treating restless legs syndrome are fairly low, relative to the improved symptoms and associated health care outcomes, and are mainly attributable to prescription medication. Health plans are encouraged to expand coverage to reduce the associated suffering and costs.

John Barron, PharmD Ralph Turner, PhD Michael Jaeger, MD Wallace Adamson, MD Joseph Singer, MD

Patients treated with oral linezolid, covered under the pharmacy benefit, had lower re-hospitalizations and emergency room visits than patients treated with vancomycin or daptomycin, covered under the medical benefit

Setareh A. Williams, PhD Erin K. Buysman, MS Erin M. Hulbert, MS Joette Gdovin Bergeson, PhD Bin Zhang, MD John Graham, PharmD

This study verifies, as defined by current guidelines, that initial treatment with fixed dose combinations (FDC) is associated with a better likelihood of HbA1c goal attainment and lower health care resource use and costs.


MANAGED CARE’s Weekly Poll

How will the Supreme Court rule in King v. Burwell?

Any day now, the Supreme Court will hand down its decision. How will the court rule?

In favor of Burwell, upholding the subsidies and leaving the ACA intact
68% (126 votes)
In favor of the plaintiff, King, and against premium subsidies for insurance policies sold on federally facilitated exchanges
32% (58 votes)
Total votes: 184